Literature DB >> 28756692

The safety of available treatments for chronic constipation.

Blanca Serrano-Falcón1, Enrique Rey1.   

Abstract

INTRODUCTION: Chronic constipation is a frequent syndrome which, not only causes an appreciable deterioration in quality of life, but also entails a high economic cost due, among other things, to its treatment. This is because of the widespread use of laxatives, even by subjects who have not sought medical care, as well as little patient satisfaction with the treatment. Although this generally involves the use of drugs regarded as safe, there is no clear evidence about their short- and long-term effects, something that complicates appropriate prescription and follow-up by health professionals and hinders therapeutic compliance.
OBJECTIVE: To review the adverse effects which have been associated with laxatives based on scientific evidence, and ascertain the safety profile of the treatments used for constipation. Expert opinion: While all the drugs currently available for treatment of constipation are generally safe when used at established doses under medical supervision, more rigorous data on their long-term safety are nonetheless required, in view of the fact that constipation is a chronic condition. Their long-term use should be monitored by health professionals to optimize treatment on an individualized basis, with the aim of enhancing efficacy and minimizing adverse effects.

Entities:  

Keywords:  Constipation; adverse effects; laxatives; linaclotide; lubiprostone; prucalopride

Mesh:

Substances:

Year:  2017        PMID: 28756692     DOI: 10.1080/14740338.2017.1361402

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  5 in total

1.  Comparing the Efficacy of Two Drugs Senalin and Bisacodyl in Treatment of Constipation in Intensive Care Units' Patients.

Authors:  Babak Alikiaii; Mohammad Azad Majedi; Seyed Taghi Hashemi; Maryam Kiani
Journal:  Adv Biomed Res       Date:  2019-02-27

2.  Comparison of Taiji and aerobic exercise for functional constipation: study protocol for a randomised controlled neuroimaging trial.

Authors:  Sha Yang; Jingwen Chen; Yuyi Guo; Yuke Teng; Tianyu Liu; Rongtao Ying; Zhaoxuan He; Jianwei Wu; Shu-Guang Yu; Fang Zeng
Journal:  BMJ Open       Date:  2019-08-30       Impact factor: 2.692

3.  Opioid-induced bowel dysfunction: suggestions from a multidisciplinary expert Board.

Authors:  Marco Rossi; Giuseppe Casale; Danilo Badiali; Federica Aielli; Maria Antonietta Aloe Spiriti; Roberto Arcioni; Francesca Bordin; Maurizio Ferrara; Gloria Morelli Sbarra; Antonio Corcione; Franco Marinangeli; Paolo Marchetti
Journal:  Support Care Cancer       Date:  2019-02-18       Impact factor: 3.603

4.  Effect of Portulaca Oleracea L. extract on functional constipation: A randomized, double-blind, placebo-controlled trial.

Authors:  Ki Bae Bang; Jung Ho Choi; Jee Hun Park; Seong Lee; Mun-Chual Rho; Seung W Lee; Soyoung Lee; Jeong Eun Shin
Journal:  Saudi J Gastroenterol       Date:  2022 Jul-Aug       Impact factor: 3.214

5.  Laxative Use and Change in Estimated Glomerular Filtration Rate in Patients With Advanced Chronic Kidney Disease.

Authors:  Keiichi Sumida; Ankur A Dashputre; Praveen K Potukuchi; Fridtjof Thomas; Yoshitsugu Obi; Miklos Z Molnar; Justin D Gatwood; Elani Streja; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  J Ren Nutr       Date:  2020-09-18       Impact factor: 4.354

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.